In addition to the aforementioned literature’s illustration of the feasibility of UTMD as a gene transfection modality to treat breast cancer, another study by Hui Luo et al. evidenced that silenced PRR11 mediated by US exhibited a higher efficiency than that mediated by lipofectamine 3000 [40]. This evidence concerns the gene PRR11 and breast carcinoma.